Erratum to: "Prognostic Significance of β-Catenin in Colorectal Cancer with Liver Metastasis" (Clin Oncol 2006;18(10):761-767) (DOI:10.1016/j.clon.2006.08.007);Prognostic Significance of β-catenin in Colorectal Cancer with Liver Metastasis

Clinical Oncology

Volumn 18, Issue 10, 2006, Pages 761-767

  Han, S A ^a   Chun, H ^a   Park, C M ^a   Kang, S J ^a   Kim, S H ^b   Sohn, D ^b   Yun, S H ^a   Lee, W Y ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

colorectal cancer; immunohistochemistry; metastatic liver cancer; tissue microarray; Catenin

Indexed keywords

BETA CATENIN; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER TISSUE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TISSUE MICROARRAY;

EID: 33750438082     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.02.006     Document Type: Erratum

References (29)

1. Wanebo H.J., Chu Q.D., Vezeridis M.P., and Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 131 (1996) 322
2. Salo J.C., Paty P.B., Guillem J., Minsky B.D., Harrison L.B., and Cohen A.M. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 6 (1999) 171
3. Blumgart L.H., and Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32 (1995) 335
4. Scheele J., Stangl R., Altendorf-Hofmann A., and Gall F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 (1991) 13
5. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver; a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77 (1996) 1254
6. Beavon I.R.G. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36 (2000) 1607
7. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9 (1993) 317
8. Ozawa M., and Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol 116 (1992) 989
9. Hugh T.J., Dillon S.A., O'Dowd G., et al. β-Catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 82 (1999) 504
10. Choi Y.S., Shim Y.M., Kim S.H., et al. Prognostic significance of E-cadherin and β-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 24 (2003) 441
11. Resnick M.B., Routhier J., Konkin T., Sabo E., and Pricolo V.E. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 10 (2004) 3069
12. Shiozaki H., Tahara H., and Oka H. Expression of immuno-reactive E-cadherin adhesion molecules in human cancer. Am J Pathol 139 (1991) 17
13. Shimoyama Y., and Hironashi S. Expression of E- and P-cadherin in gastric carcinoma. Cancer Res 51 (1991) 2185
14. Hoos A., Urist M.J., Stojadinovic A., et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158 (2001) 1245
15. Jourdan F., Sebbagh N., Comperat E., et al. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443 (2003) 115
16. Gofuku J., Shiozaki H., Tsujinaka T., et al. Expression of E-cadherin and α-catenin in patients with colorectal carcinoma. Am J Clin Pathol 111 (1999) 29
17. Ghadimi B.M., Behrens J., Hoffmann I., Haensch W., Birchmeier W., and Schlag P.M. Immunohistological analysis of E-cadherin, α-, β- and γ-catenin expression in colorectal cancer: implications for cell adhesion and signal. Eur J Cancer 35 (1999) 60
18. Fernebro E., Bendahl P.O., Dictor M., Persson A., Ferno M., and Nilbert M. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations. Int J Cancer 111 (2004) 921
19. Ikeguchi M., Makino M., and Kaibara N. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol 77 (2001) 201
20. Behrens J., Jerchow B.A., Würtele M., et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC and GSK 3β. Science 280 (1998) 596
21. Hart M.J., de los Santos R., Albert I., Rubinfeld B., and Polakis P. Down-regulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Curr Biol 8 (1998) 573
22. Sakanaka C., Weiss J.B., and Williams L.T. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription. Proc Natl Acad Sci U S A 95 (1998) 3020
23. Rosin-Arbesfeld R., Townsley F., and Bienz M. The APC tumour suppressor has a nuclear export function. Nature 406 (2000) 1009
24. Brabletz T., Herrmann K., Jung A., Faller G., and Kirchner T. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 156 (2000) 865
25. Mann B., Gelos M., Siedow A., et al. Target genes of β-catenin-T cell-factor/lymphoid-enhance-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96 (1999) 1603
26. He T.C., Sparks A.B., Rago C., et al. Identification of c-myc as a target of the APC pathway. Science 281 (1998) 1509
27. Shtutman M., Zhurinsky J., Simcha I., et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96 (1999) 5522
28. Hao X., Palazzo J.P., Ilyas M., Tomlinson I., and Talbot I.C. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Anticancer Res 17 (1997) 2241
29. Herter P., Kuhnen C., Müller K.M., Wittinghofer A., and Müller O. Intracellular distribution of β-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. J Cancer Res Clin Oncol 125 (1999) 297